Global Newcastle Disease Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Global Newcastle Disease Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Newcastle Disease Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Newcastle Disease Vaccine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market by Application
1.3.1 Global Newcastle Disease Vaccine Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Newcastle Disease Vaccine Market Size Estimates and Forecasts
2.1.1 Global Newcastle Disease Vaccine Revenue 2017-2028
2.1.2 Global Newcastle Disease Vaccine Sales 2017-2028
2.2 Newcastle Disease Vaccine Market Size by Region: 2022 Versus 2028
2.3 Newcastle Disease Vaccine Sales by Region (2017-2028)
2.3.1 Global Newcastle Disease Vaccine Sales by Region: 2017-2022
2.3.2 Global Newcastle Disease Vaccine Sales Forecast by Region (2023-2028)
2.3.3 Global Newcastle Disease Vaccine Sales Market Share by Region (2017-2028)
2.4 Newcastle Disease Vaccine Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Newcastle Disease Vaccine Revenue by Region: 2017-2022
2.4.2 Global Newcastle Disease Vaccine Revenue Forecast by Region (2023-2028)
2.4.3 Global Newcastle Disease Vaccine Revenue Market Share by Region (2017-2028)
3 Global Newcastle Disease Vaccine by Manufacturers
3.1 Global Top Newcastle Disease Vaccine Manufacturers by Sales
3.1.1 Global Newcastle Disease Vaccine Sales by Manufacturer (2017-2022)
3.1.2 Global Newcastle Disease Vaccine Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Newcastle Disease Vaccine Manufacturers by Revenue
3.2.1 Global Newcastle Disease Vaccine Revenue by Manufacturer (2017-2022)
3.2.2 Global Newcastle Disease Vaccine Revenue Share by Manufacturer (2017-2022)
3.3 Global Newcastle Disease Vaccine Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Newcastle Disease Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Newcastle Disease Vaccine Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Newcastle Disease Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Newcastle Disease Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Newcastle Disease Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Newcastle Disease Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Merial
4.1.1 Merial Corporation Information
4.1.2 Merial Description, Business Overview
4.1.3 Merial Newcastle Disease Vaccine Products Offered
4.1.4 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Merial Newcastle Disease Vaccine Sales by Product in 2021
4.1.6 Merial Newcastle Disease Vaccine Sales by Application in 2021
4.1.7 Merial Newcastle Disease Vaccine Sales by Geographic Area in 2021
4.1.8 Merial Recent Developments
4.2 CEVA
4.2.1 CEVA Corporation Information
4.2.2 CEVA Description, Business Overview
4.2.3 CEVA Newcastle Disease Vaccine Products Offered
4.2.4 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.2.5 CEVA Newcastle Disease Vaccine Sales by Product in 2021
4.2.6 CEVA Newcastle Disease Vaccine Sales by Application in 2021
4.2.7 CEVA Newcastle Disease Vaccine Sales by Geographic Area in 2021
4.2.8 CEVA Recent Developments
4.3 QYH Biotech
4.3.1 QYH Biotech Corporation Information
4.3.2 QYH Biotech Description, Business Overview
4.3.3 QYH Biotech Newcastle Disease Vaccine Products Offered
4.3.4 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.3.5 QYH Biotech Newcastle Disease Vaccine Sales by Product in 2021
4.3.6 QYH Biotech Newcastle Disease Vaccine Sales by Application in 2021
4.3.7 QYH Biotech Newcastle Disease Vaccine Sales by Geographic Area in 2021
4.3.8 QYH Biotech Recent Developments
4.4 Ringpu Biology
4.4.1 Ringpu Biology Corporation Information
4.4.2 Ringpu Biology Description, Business Overview
4.4.3 Ringpu Biology Newcastle Disease Vaccine Products Offered
4.4.4 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Ringpu Biology Newcastle Disease Vaccine Sales by Product in 2021
4.4.6 Ringpu Biology Newcastle Disease Vaccine Sales by Application in 2021
4.4.7 Ringpu Biology Newcastle Disease Vaccine Sales by Geographic Area in 2021
4.4.8 Ringpu Biology Recent Developments
4.5 Yebio
4.5.1 Yebio Corporation Information
4.5.2 Yebio Description, Business Overview
4.5.3 Yebio Newcastle Disease Vaccine Products Offered
4.5.4 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Yebio Newcastle Disease Vaccine Sales by Product in 2021
4.5.6 Yebio Newcastle Disease Vaccine Sales by Application in 2021
4.5.7 Yebio Newcastle Disease Vaccine Sales by Geographic Area in 2021
4.5.8 Yebio Recent Developments
4.6 Harbin Veterinary Research Institute
4.6.1 Harbin Veterinary Research Institute Corporation Information
4.6.2 Harbin Veterinary Research Institute Description, Business Overview
4.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Products Offered
4.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales by Product in 2021
4.6.6 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales by Application in 2021
4.6.7 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales by Geographic Area in 2021
4.6.8 Harbin Veterinary Research Institute Recent Development
4.7 Merck Animal Health
4.7.1 Merck Animal Health Corporation Information
4.7.2 Merck Animal Health Description, Business Overview
4.7.3 Merck Animal Health Newcastle Disease Vaccine Products Offered
4.7.4 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Merck Animal Health Newcastle Disease Vaccine Sales by Product in 2021
4.7.6 Merck Animal Health Newcastle Disease Vaccine Sales by Application in 2021
4.7.7 Merck Animal Health Newcastle Disease Vaccine Sales by Geographic Area in 2021
4.7.8 Merck Animal Health Recent Development
4.8 DHN
4.8.1 DHN Corporation Information
4.8.2 DHN Description, Business Overview
4.8.3 DHN Newcastle Disease Vaccine Products Offered
4.8.4 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.8.5 DHN Newcastle Disease Vaccine Sales by Product in 2021
4.8.6 DHN Newcastle Disease Vaccine Sales by Application in 2021
4.8.7 DHN Newcastle Disease Vaccine Sales by Geographic Area in 2021
4.8.8 DHN Recent Development
4.9 Zoetis
4.9.1 Zoetis Corporation Information
4.9.2 Zoetis Description, Business Overview
4.9.3 Zoetis Newcastle Disease Vaccine Products Offered
4.9.4 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Zoetis Newcastle Disease Vaccine Sales by Product in 2021
4.9.6 Zoetis Newcastle Disease Vaccine Sales by Application in 2021
4.9.7 Zoetis Newcastle Disease Vaccine Sales by Geographic Area in 2021
4.9.8 Zoetis Recent Development
4.10 ChengDu Tecbond
4.10.1 ChengDu Tecbond Corporation Information
4.10.2 ChengDu Tecbond Description, Business Overview
4.10.3 ChengDu Tecbond Newcastle Disease Vaccine Products Offered
4.10.4 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.10.5 ChengDu Tecbond Newcastle Disease Vaccine Sales by Product in 2021
4.10.6 ChengDu Tecbond Newcastle Disease Vaccine Sales by Application in 2021
4.10.7 ChengDu Tecbond Newcastle Disease Vaccine Sales by Geographic Area in 2021
4.10.8 ChengDu Tecbond Recent Development
4.11 Elanco (Lohmann)
4.11.1 Elanco (Lohmann) Corporation Information
4.11.2 Elanco (Lohmann) Description, Business Overview
4.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Products Offered
4.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Elanco (Lohmann) Newcastle Disease Vaccine Sales by Product in 2021
4.11.6 Elanco (Lohmann) Newcastle Disease Vaccine Sales by Application in 2021
4.11.7 Elanco (Lohmann) Newcastle Disease Vaccine Sales by Geographic Area in 2021
4.11.8 Elanco (Lohmann) Recent Development
4.12 FATRO
4.12.1 FATRO Corporation Information
4.12.2 FATRO Description, Business Overview
4.12.3 FATRO Newcastle Disease Vaccine Products Offered
4.12.4 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.12.5 FATRO Newcastle Disease Vaccine Sales by Product in 2021
4.12.6 FATRO Newcastle Disease Vaccine Sales by Application in 2021
4.12.7 FATRO Newcastle Disease Vaccine Sales by Geographic Area in 2021
4.12.8 FATRO Recent Development
4.13 CAVAC
4.13.1 CAVAC Corporation Information
4.13.2 CAVAC Description, Business Overview
4.13.3 CAVAC Newcastle Disease Vaccine Products Offered
4.13.4 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.13.5 CAVAC Newcastle Disease Vaccine Sales by Product in 2021
4.13.6 CAVAC Newcastle Disease Vaccine Sales by Application in 2021
4.13.7 CAVAC Newcastle Disease Vaccine Sales by Geographic Area in 2021
4.13.8 CAVAC Recent Development
4.14 Vaksindo
4.14.1 Vaksindo Corporation Information
4.14.2 Vaksindo Description, Business Overview
4.14.3 Vaksindo Newcastle Disease Vaccine Products Offered
4.14.4 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.14.5 Vaksindo Newcastle Disease Vaccine Sales by Product in 2021
4.14.6 Vaksindo Newcastle Disease Vaccine Sales by Application in 2021
4.14.7 Vaksindo Newcastle Disease Vaccine Sales by Geographic Area in 2021
4.14.8 Vaksindo Recent Development
5 Breakdown Data by Type
5.1 Global Newcastle Disease Vaccine Sales by Type (2017-2028)
5.1.1 Global Newcastle Disease Vaccine Sales by Type (2017-2022)
5.1.2 Global Newcastle Disease Vaccine Sales Forecast by Type (2023-2028)
5.1.3 Global Newcastle Disease Vaccine Sales Market Share by Type (2017-2028)
5.2 Global Newcastle Disease Vaccine Revenue Forecast by Type (2017-2028)
5.2.1 Global Newcastle Disease Vaccine Revenue by Type (2017-2022)
5.2.2 Global Newcastle Disease Vaccine Revenue Forecast by Type (2023-2028)
5.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Type (2017-2028)
5.3 Newcastle Disease Vaccine Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Newcastle Disease Vaccine Sales by Application (2017-2028)
6.1.1 Global Newcastle Disease Vaccine Sales by Application (2017-2022)
6.1.2 Global Newcastle Disease Vaccine Sales Forecast by Application (2023-2028)
6.1.3 Global Newcastle Disease Vaccine Sales Market Share by Application (2017-2028)
6.2 Global Newcastle Disease Vaccine Revenue Forecast by Application (2017-2028)
6.2.1 Global Newcastle Disease Vaccine Revenue by Application (2017-2022)
6.2.2 Global Newcastle Disease Vaccine Revenue Forecast by Application (2023-2028)
6.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Application (2017-2028)
6.3 Newcastle Disease Vaccine Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Newcastle Disease Vaccine Market Size YoY Growth 2017-2028
7.2 North America Newcastle Disease Vaccine Market Facts & Figures by Country
7.2.1 North America Newcastle Disease Vaccine Sales by Country (2017-2028)
7.2.2 North America Newcastle Disease Vaccine Revenue by Country (2017-2028)
7.3 North America Newcastle Disease Vaccine Sales by Type
7.4 North America Newcastle Disease Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Newcastle Disease Vaccine Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Newcastle Disease Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Newcastle Disease Vaccine Sales by Region (2017-2028)
8.2.2 Asia-Pacific Newcastle Disease Vaccine Revenue by Region (2017-2028)
8.3 Asia-Pacific Newcastle Disease Vaccine Sales by Type
8.4 Asia-Pacific Newcastle Disease Vaccine Sales by Application
9 Europe
9.1 Europe Newcastle Disease Vaccine Market Size YoY Growth 2017-2028
9.2 Europe Newcastle Disease Vaccine Market Facts & Figures by Country
9.2.1 Europe Newcastle Disease Vaccine Sales by Country (2017-2028)
9.2.2 Europe Newcastle Disease Vaccine Revenue by Country (2017-2028)
9.3 Europe Newcastle Disease Vaccine Sales by Type
9.4 Europe Newcastle Disease Vaccine Sales by Application
10 Latin America
10.1 Latin America Newcastle Disease Vaccine Market Size YoY Growth 2017-2028
10.2 Latin America Newcastle Disease Vaccine Market Facts & Figures by Country
10.2.1 Latin America Newcastle Disease Vaccine Sales by Country (2017-2028)
10.2.2 Latin America Newcastle Disease Vaccine Revenue by Country (2017-2028)
10.3 Latin America Newcastle Disease Vaccine Sales by Type
10.4 Latin America Newcastle Disease Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Newcastle Disease Vaccine Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Newcastle Disease Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Newcastle Disease Vaccine Sales by Country (2017-2028)
11.2.2 Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2017-2028)
11.3 Middle East and Africa Newcastle Disease Vaccine Sales by Type
11.4 Middle East and Africa Newcastle Disease Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Newcastle Disease Vaccine Supply Chain Analysis
12.2 Newcastle Disease Vaccine Key Raw Materials and Upstream Suppliers
12.3 Newcastle Disease Vaccine Clients Analysis
12.4 Newcastle Disease Vaccine Sales Channel and Sales Model Analysis
12.4.1 Newcastle Disease Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Newcastle Disease Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Newcastle Disease Vaccine Distributors
13 Market Dynamics
13.1 Newcastle Disease Vaccine Industry Trends
13.2 Newcastle Disease Vaccine Market Drivers
13.3 Newcastle Disease Vaccine Market Challenges
13.4 Newcastle Disease Vaccine Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Newcastle Disease Vaccine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Live Vaccines
Table 3. Major Manufacturers of Killed Vaccines
Table 4. Global Newcastle Disease Vaccine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Newcastle Disease Vaccine Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 6. Global Newcastle Disease Vaccine Sales by Region (2017-2022) & (M Doses)
Table 7. Global Newcastle Disease Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
Table 8. Global Newcastle Disease Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Newcastle Disease Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 10. Global Newcastle Disease Vaccine Sales by Manufacturer (2017-2022) & (M Doses)
Table 11. Global Newcastle Disease Vaccine Sales Share by Manufacturer (2017-2022)
Table 12. Newcastle Disease Vaccine Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 13. Newcastle Disease Vaccine Revenue Share by Manufacturer (2017-2022)
Table 14. Key Manufacturers Newcastle Disease Vaccine Price (2017-2022) & (USD/K Doses)
Table 15. Ranking of Global Top Newcastle Disease Vaccine Manufacturers by Revenue (US$ Million) in 2021
Table 16. Global Newcastle Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 17. Global Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Newcastle Disease Vaccine as of 2021)
Table 18. Newcastle Disease Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Newcastle Disease Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Newcastle Disease Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Merial Corporation Information
Table 23. Merial Description and Business Overview
Table 24. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 25. Merial Newcastle Disease Vaccine Product
Table 26. Merial Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Product in 2021
Table 27. Merial Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Application in 2021
Table 28. Merial Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Geographic Area in 2021
Table 29. Merial Recent Development
Table 30. CEVA Corporation Information
Table 31. CEVA Description and Business Overview
Table 32. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 33. CEVA Newcastle Disease Vaccine Product
Table 34. CEVA Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Product in 2021
Table 35. CEVA Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Application in 2021
Table 36. CEVA Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Geographic Area in 2021
Table 37. CEVA Recent Development
Table 38. QYH Biotech Corporation Information
Table 39. QYH Biotech Description and Business Overview
Table 40. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 41. QYH Biotech Newcastle Disease Vaccine Product
Table 42. QYH Biotech Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Product in 2021
Table 43. QYH Biotech Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Application in 2021
Table 44. QYH Biotech Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Geographic Area in 2021
Table 45. QYH Biotech Recent Development
Table 46. Ringpu Biology Corporation Information
Table 47. Ringpu Biology Description and Business Overview
Table 48. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 49. Ringpu Biology Newcastle Disease Vaccine Product
Table 50. Ringpu Biology Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Product in 2021
Table 51. Ringpu Biology Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Application in 2021
Table 52. Ringpu Biology Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Geographic Area in 2021
Table 53. Ringpu Biology Recent Development
Table 54. Yebio Corporation Information
Table 55. Yebio Description and Business Overview
Table 56. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 57. Yebio Newcastle Disease Vaccine Product
Table 58. Yebio Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Product in 2021
Table 59. Yebio Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Application in 2021
Table 60. Yebio Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Geographic Area in 2021
Table 61. Yebio Recent Development
Table 62. Harbin Veterinary Research Institute Corporation Information
Table 63. Harbin Veterinary Research Institute Description and Business Overview
Table 64. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 65. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product
Table 66. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Product in 2021
Table 67. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Application in 2021
Table 68. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Geographic Area in 2021
Table 69. Merck Animal Health Corporation Information
Table 70. Merck Animal Health Description and Business Overview
Table 71. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 72. Merck Animal Health Newcastle Disease Vaccine Product
Table 73. Merck Animal Health Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Product in 2021
Table 74. Merck Animal Health Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Application in 2021
Table 75. Merck Animal Health Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Geographic Area in 2021
Table 76. DHN Corporation Information
Table 77. DHN Description and Business Overview
Table 78. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 79. DHN Newcastle Disease Vaccine Product
Table 80. DHN Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Product in 2021
Table 81. DHN Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Application in 2021
Table 82. DHN Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Geographic Area in 2021
Table 83. Zoetis Corporation Information
Table 84. Zoetis Description and Business Overview
Table 85. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 86. Zoetis Newcastle Disease Vaccine Product
Table 87. Zoetis Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Product in 2021
Table 88. Zoetis Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Application in 2021
Table 89. Zoetis Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Geographic Area in 2021
Table 90. ChengDu Tecbond Corporation Information
Table 91. ChengDu Tecbond Description and Business Overview
Table 92. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 93. ChengDu Tecbond Newcastle Disease Vaccine Product
Table 94. ChengDu Tecbond Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Product in 2021
Table 95. ChengDu Tecbond Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Application in 2021
Table 96. ChengDu Tecbond Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Geographic Area in 2021
Table 97. Elanco (Lohmann) Corporation Information
Table 98. Elanco (Lohmann) Description and Business Overview
Table 99. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 100. Elanco (Lohmann) Newcastle Disease Vaccine Product
Table 101. Elanco (Lohmann) Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Product in 2021
Table 102. Elanco (Lohmann) Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Application in 2021
Table 103. Elanco (Lohmann) Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Geographic Area in 2021
Table 104. FATRO Corporation Information
Table 105. FATRO Description and Business Overview
Table 106. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 107. FATRO Newcastle Disease Vaccine Product
Table 108. FATRO Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Product in 2021
Table 109. FATRO Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Application in 2021
Table 110. FATRO Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Geographic Area in 2021
Table 111. CAVAC Corporation Information
Table 112. CAVAC Description and Business Overview
Table 113. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 114. CAVAC Newcastle Disease Vaccine Product
Table 115. CAVAC Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Product in 2021
Table 116. CAVAC Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Application in 2021
Table 117. CAVAC Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Geographic Area in 2021
Table 118. Vaksindo Corporation Information
Table 119. Vaksindo Description and Business Overview
Table 120. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 121. Vaksindo Newcastle Disease Vaccine Product
Table 122. Vaksindo Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Product in 2021
Table 123. Vaksindo Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Application in 2021
Table 124. Vaksindo Newcastle Disease Vaccine Sales Proportion of Newcastle Disease Vaccine by Geographic Area in 2021
Table 125. Global Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
Table 126. Global Newcastle Disease Vaccine Sales Forecast by Type (2023-2028) & (M Doses)
Table 127. Global Newcastle Disease Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 128. Global Newcastle Disease Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 129. Global Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
Table 130. Global Newcastle Disease Vaccine Sales Forecast by Application (2023-2028) & (M Doses)
Table 131. Global Newcastle Disease Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 132. Global Newcastle Disease Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 133. North America Newcastle Disease Vaccine Sales by Country (2017-2022) & (M Doses)
Table 134. North America Newcastle Disease Vaccine Sales by Country (2023-2028) & (M Doses)
Table 135. North America Newcastle Disease Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 136. North America Newcastle Disease Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 137. North America Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
Table 138. North America Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
Table 139. Asia-Pacific Newcastle Disease Vaccine Sales by Region (2017-2022) & (M Doses)
Table 140. Asia-Pacific Newcastle Disease Vaccine Sales by Region (2023-2028) & (M Doses)
Table 141. Asia-Pacific Newcastle Disease Vaccine Revenue by Region (2017-2028) & (US$ Million)
Table 142. Asia-Pacific Newcastle Disease Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 143. Asia-Pacific Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
Table 144. Asia-Pacific Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
Table 145. Europe Newcastle Disease Vaccine Sales by Country (2017-2022) & (M Doses)
Table 146. Europe Newcastle Disease Vaccine Sales by Country (2023-2028) & (M Doses)
Table 147. Europe Newcastle Disease Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 148. Europe Newcastle Disease Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 149. Europe Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
Table 150. Europe Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
Table 151. Latin America Newcastle Disease Vaccine Sales by Country (2017-2022) & (M Doses)
Table 152. Latin America Newcastle Disease Vaccine Sales by Country (2023-2028) & (M Doses)
Table 153. Latin America Newcastle Disease Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 154. Latin America Newcastle Disease Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 155. Latin America Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
Table 156. Latin America Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
Table 157. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2017-2022) & (M Doses)
Table 158. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2023-2028) & (M Doses)
Table 159. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 160. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 161. Middle East and Africa Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
Table 162. Middle East and Africa Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
Table 163. Newcastle Disease Vaccine Key Raw Materials, Industry Status and Trend
Table 164. Newcastle Disease Vaccine Key Raw Materials and Upstream Suppliers
Table 165. Newcastle Disease Vaccine Clients Status and Trend
Table 166. Newcastle Disease Vaccine Typical Clients
Table 167. Newcastle Disease Vaccine Distributors
Table 168. Newcastle Disease Vaccine Market Trends
Table 169. Newcastle Disease Vaccine Market Drivers
Table 170. Newcastle Disease Vaccine Market Challenges
Table 171. Newcastle Disease Vaccine Market Restraints
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Newcastle Disease Vaccine Product Picture
Figure 2. Global Newcastle Disease Vaccine Sales Market Share by Type in 2021 & 2028
Figure 3. Live Vaccines Product Picture
Figure 4. Killed Vaccines Product

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Classical Swine Fever Vaccines Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......

Global Tylosin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......

Global Animal Parasiticides Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......

Global Newcastle Disease Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......

Global Classical Swine Fever Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126

According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......

Global Veterinary Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151

According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......

Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......

Global Veterinary Products for Companion Animals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......

Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115

According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs